Yüklüyor......
PD-1 inhibition and treatment of advanced melanoma-role of pembrolizumab
Remarkable clinical responses have been seen in patients with metastatic melanoma with targeted therapy (BRAFi vemurafenib, MEKi) and with modern immune cell-based approaches such as TCR engineered adoptive cell transfer (ACT) and earlier experiences with high-dose IL-2. The proximal mediators of th...
Kaydedildi:
| Yayımlandı: | Am J Cancer Res |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
e-Century Publishing Corporation
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5088280/ https://ncbi.nlm.nih.gov/pubmed/27822406 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|